학술논문

In situ immunization with the TLR9-agonist CMP-001 enhances anti-PD1 therapy in head and neck tumors
Document Type
Journal
Source
CANCER RESEARCH; AUG 2020, 80 16, 2p. Supplement: S
Subject
Language
English
ISSN
15387445